KPL3,520.00

Kwality Pharmaceuticals Limited

· Pharma & Health
₹ CrorePeersBPLPHARMAJENBURPHMAKERSLNOVARTINDPARNAXLABSGRLSHUKRAPHARSUNLOC
View
In ₹ Crore except Per Share
12 Months Ending
FY22
31/03/2022
FY23
31/03/2023
FY24
31/03/2024
Non-current Assets
+ Property, Plant & Equipment90.8119.6138.2
+ Capital Work-in-Progress12.114.30.0
+ Intangibles under Development4.3
+ Non-current Investments3.53.5
+ Long-term Loans8.1
Non-current Financial Assets3.5
+ Deferred Tax Assets0.0133.90.1
+ Other Non-current Assets0.011.612.4
Total Non-current Assets149.1154.2
Current Assets
+ Inventories53.486.378.4
+ Trade Receivables70.773.3116.0
+ Cash & Cash Equivalents10.9
+ Other Bank Balances1.81.4
+ Short-term Loans92.410.3
+ Other Current Assets0.024.627.6
Total Current Assets207.5243.4
Total Assets342.7356.6397.6
Equity
+ Equity Share Capital10.410.410.4
+ Other Equity / Reserves191.6215.6
Equity — Owners of Parent202.0225.9
Total Equity202.0225.9
Liabilities
+ Borrowings — Non-current19.6
Non-current Financial Liabilities19.6
+ Provisions — Non-current0.2
+ Deferred Tax Liabilities0.30.40.0
Non-current Liabilities28.619.8
+ Borrowings — Current78.6
+ Trade Payables34.535.244.3
+ Provisions — Current0.2
+ Other Current Liabilities31.119.1
Current Liabilities125.9151.9
Total Liabilities154.6171.6
Total Equity & Liabilities342.7356.6397.6
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY24 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 85%.